interleukin-6

interleukin-6
Name	Interleukin-6
Organism	Homo sapiens
Uniprot	P05231
Type	Cytokine

interleukin-6 is a multifunctional cytokine involved in immune regulation, inflammation, hematopoiesis, and metabolism. First characterized in the late 20th century, it has been studied across biomedical research institutions such as the National Institutes of Health, Harvard University, Stanford University, University of Cambridge, and Karolinska Institutet. Its relevance spans clinical settings in hospitals like Mayo Clinic and Cleveland Clinic and features in guidelines by organizations including the World Health Organization and the European Medicines Agency.

Structure and Biosynthesis

The precursor polypeptide is encoded on chromosome 7 and translated in the rough endoplasmic reticulum before secretion via the Golgi apparatus, a process interrogated in labs at Massachusetts Institute of Technology, Cold Spring Harbor Laboratory, and Max Planck Society. Structural studies using techniques from groups at European Molecular Biology Laboratory, Rutherford Appleton Laboratory, and Lawrence Berkeley National Laboratory revealed a four-helix bundle common to the interleukin family, with glycosylation sites defined by work from teams at University of Oxford, Johns Hopkins University, and Imperial College London. Biosynthesis is regulated transcriptionally by factors such as NF-κB and AP-1, pathways explored by researchers at Caltech, Yale University, and University of California, San Francisco, and post-transcriptionally by microRNAs studied at University of Tokyo and Seoul National University.

Receptors and Signaling Pathways

Signaling is mediated by binding to a specific cell-surface receptor complex comprising an α subunit and the gp130 signal transducer, the latter studied by groups at University of Pennsylvania, University of Chicago, and University of Toronto. Downstream activation engages JAK/STAT cascades characterized in seminal work from David Baltimore-associated laboratories and from teams at Rockefeller University, invoking Janus kinase family members and STAT3 phosphorylation documented at Institut Pasteur. Alternative signaling modes include trans-signaling via soluble receptor variants and trans-presentation described in reviews from King's College London and University of Birmingham. Cross-talk with MAPK and PI3K/AKT pathways has been detailed by investigators at École Normale Supérieure, University of Melbourne, and National University of Singapore.

Physiological Functions

Interleukin-6 contributes to acute-phase responses orchestrated by the liver and regulated in clinical hepatology units at Mount Sinai Hospital and Royal Free Hospital, stimulating synthesis of proteins such as C-reactive protein; roles in B cell differentiation and T cell subset polarization were defined in immunology departments at Weizmann Institute of Science and Pasteur Institute. It influences metabolic homeostasis studied at University of Copenhagen and McGill University, affects neuroimmune interactions probed at University College London and Columbia University, and participates in hematopoiesis investigated at Fred Hutchinson Cancer Research Center and Dana-Farber Cancer Institute. Developmental and regenerative functions have been observed in models used by Scripps Research and University of California, San Diego.

Role in Disease and Pathology

Dysregulated signaling contributes to chronic inflammatory disorders investigated by clinicians at Johns Hopkins Hospital and Guy's Hospital, with implicated conditions including rheumatoid arthritis, explored in trials at Royal National Hospital for Rheumatic Diseases and Hospital for Special Surgery, and cytokine release syndrome described in reports from St. Jude Children's Research Hospital and Children's Hospital of Philadelphia. Associations with oncogenesis have been reported in studies from MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center, affecting tumor microenvironment and cachexia addressed by researchers at National Cancer Institute and Dana-Farber. Its role in infectious disease immune responses was highlighted during outbreaks tracked by Centers for Disease Control and Prevention and investigations during the COVID-19 pandemic by global consortia including World Health Organization teams. Cardiovascular, metabolic, and neurodegenerative links have been subjects of research at Mount Sinai Medical Center, Beth Israel Deaconess Medical Center, and Karolinska University Hospital.

Clinical Measurement and Biomarkers

Serum or plasma concentrations are measured by immunoassays developed by companies such as Roche, Abbott Laboratories, and Thermo Fisher Scientific, and validated in clinical chemistry laboratories at Mayo Clinic and Quest Diagnostics. Standardization efforts involve organizations including the International Organization for Standardization and the Clinical & Laboratory Standards Institute. Biomarker utility has been evaluated in multicenter studies coordinated by networks like European League Against Rheumatism and National Institutes of Health consortia, used for prognostication in sepsis trials run by Imperial College Healthcare NHS Trust and for monitoring treatment response in randomized controlled trials at Cochrane-affiliated centers.

Therapeutic Targeting and Drugs

Therapeutic blockade has been achieved with monoclonal antibodies and receptor antagonists developed by pharmaceutical companies such as Hoffmann-La Roche, Genentech, Novartis, and AbbVie, and tested in clinical trials overseen by regulatory authorities including the Food and Drug Administration and the European Medicines Agency. Approved agents targeting the pathway are used in indications studied in randomized trials at University Hospital Basel and Karolinska Institutet, while small-molecule JAK inhibitors that modulate downstream signaling have been developed by firms like Pfizer and Eli Lilly. Ongoing research into precision medicine approaches involves collaborations among Wellcome Trust, Bill & Melinda Gates Foundation, and academic centers such as Broad Institute and Sanger Institute.

Category:Cytokines